ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,309,364 | +26.9% | 73,501 | -2.9% | 1.21% | +21.9% |
| Q1 2019 | $3,394,572 | +7.1% | 75,721 | -6.9% | 0.99% | -42.3% |
| Q4 2018 | $3,169,400 | -42.3% | 81,371 | -31.8% | 1.72% | -28.8% |
| Q3 2018 | $5,493,453 | -6.1% | 119,371 | -11.0% | 2.41% | -9.9% |
| Q2 2018 | $5,848,984 | -38.7% | 134,151 | -44.5% | 2.68% | -39.7% |
| Q1 2018 | $9,546,676 | – | 241,688 | – | 4.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |